G

Glenmark Life Sciences
GLS

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
-
EV
-
Shares Outstanding
-
Beta
-

Wall Street View

Analyst Rating
BUY
Analyst Target Price
₹1138.60
P/E undefinedE
-
P/Revenue undefinedE
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Glenmark Life Sciences Limited

gainify

G

Glenmark Life Sciences Limited

GLS

Glenmark Life Sciences Limited engages in the development, manufacture, and marketing of non-commoditized active pharmaceutical ingredients for various chronic therapeutic areas in India. The company offers various APIs, such as olmesartan, telmisartan, perindopril, a...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Rawjee, Yasir

Employees

IPO Date

2021-08-06

Headquarters

OIA House, 4th Floor, 470, Cardinal Gracious Road, Andheri (East), Mumbai, Maharashtra, 400099, India

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.